TORONTO, ON / ACCESSWIRE / April 24, 2024 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF)(FRA:TTX), a clinical stage…
Private Placement of $8.4 million has closed and will fund the commercial development of lead product AVERSA Fentanyl to NDA…
Novo Nordisk's Articles of Association, April 2024 Attachment Articles of Association 24 Apr 2024
KELOWNA, BC / ACCESSWIRE / April 24, 2024 / Tryp Therapeutics, Inc. ("Tryp" or the "Company") (CSE:TRYP)(OTCQB:TRYPF) is pleased to…
neurocare is revolutionizing mental health care by providing innovative methods and tools based on neurostimulation and other technologies to help…
PALO ALTO, CA / ACCESSWIRE / April 24, 2024 / Bioz, Inc., a Silicon Valley AI company, has partnered with…
UPPSALA, SE / ACCESSWIRE / April 24, 2024 / Senzime (STO:SEZI)(OTCQX:SNZZF) Senzime, an industry leader in perioperative precision-based patient monitoring…
LUND, SWEDEN / ACCESSWIRE / April 24, 2024 / Spago Nanomedical (STO:SPAGO.ST)(FRA:7UX.F) Spago Nanomedical AB (publ) announced today data from…
ANGLE signs agreement to tailor existing Parsortix-based DNA damage response assay for use in pharmaceutical R&D GUILDFORD, SURREY / ACCESSWIRE…
GOTHENBURG, SWEDEN / ACCESSWIRE / April 24, 2024 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV)First quarter 2024 (Jan 1 - Mar 31)•…